Amlodipine Besylate Granules(Dongyangguang Pharma)
苯磺酸氨氯地平颗粒（东阳光药业）
Report date: 2026/01/22 11:02:41
Base Information
Drug NameAmlodipine Besylate Granules(Dongyangguang Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangdong Dongyangguang Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesGuangdong Dongyangguang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A